A. Roseberry, M. Bunemann, J. Elavunkal, and M. Hosey. Mol Pharmacol, 59 (5):
1256-68(May 2001)Roseberry, A G Bunemann, M Elavunkal, J Hosey, M M HL50121/HL/NHLBI
NIH HHS/United States T32-GM08061/GM/NIGMS NIH HHS/United States
Research Support, U.S. Gov't, P.H.S. United States Molecular pharmacology
Mol Pharmacol. 2001 May;59(5):1256-68..
M. Lohse, K. Maurer, K. Klotz, and U. Schwabe. Br J Pharmacol, 98 (4):
1392-8(December 1989)Lohse, M J Maurer, K Klotz, K N Schwabe, U In Vitro England British
journal of pharmacology Br J Pharmacol. 1989 Dec;98(4):1392-8..
M. Bunemann, B. Brandts, D. zu Heringdorf, C. van Koppen, K. Jakobs, and L. Pott. J Physiol, (December 1995)Bunemann, M Brandts, B zu Heringdorf, D M van Koppen, C J Jakobs,
K H Pott, L In Vitro Research Support, Non-U.S. Gov't England The
Journal of physiology J Physiol. 1995 Dec 15;489 ( Pt 3):701-7..